IT1398279B1 - Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale - Google Patents

Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale

Info

Publication number
IT1398279B1
IT1398279B1 ITMI2009A001122A ITMI20091122A IT1398279B1 IT 1398279 B1 IT1398279 B1 IT 1398279B1 IT MI2009A001122 A ITMI2009A001122 A IT MI2009A001122A IT MI20091122 A ITMI20091122 A IT MI20091122A IT 1398279 B1 IT1398279 B1 IT 1398279B1
Authority
IT
Italy
Prior art keywords
vulvuses
vaginite
restoration
therapy
prevention
Prior art date
Application number
ITMI2009A001122A
Other languages
English (en)
Inventor
Claudio Franco Omini
Giuseppe Zuccari
Original Assignee
Bsd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsd filed Critical Bsd
Priority to ITMI2009A001122A priority Critical patent/IT1398279B1/it
Publication of ITMI20091122A1 publication Critical patent/ITMI20091122A1/it
Application granted granted Critical
Publication of IT1398279B1 publication Critical patent/IT1398279B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITMI2009A001122A 2009-06-25 2009-06-25 Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale IT1398279B1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2009A001122A IT1398279B1 (it) 2009-06-25 2009-06-25 Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001122A IT1398279B1 (it) 2009-06-25 2009-06-25 Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale

Publications (2)

Publication Number Publication Date
ITMI20091122A1 ITMI20091122A1 (it) 2010-12-26
IT1398279B1 true IT1398279B1 (it) 2013-02-22

Family

ID=42077602

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001122A IT1398279B1 (it) 2009-06-25 2009-06-25 Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale

Country Status (1)

Country Link
IT (1) IT1398279B1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3117827B1 (en) 2014-03-13 2021-11-03 Singapore Ze&Z International Pte. Ltd. Composition for vagina and use of the composition
IT202100023030A1 (it) * 2021-09-06 2023-03-06 Proxenia Srl Composizione per il trattamento di infezioni della mucosa endometriale e relativo kit di somministrazione

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678166B1 (fr) * 1991-06-27 1993-10-22 Bioeurope Compositions cosmetiques contenant des glucooligosaccharides.
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
FR2874825B1 (fr) * 2004-09-08 2006-12-08 Genibio Sarl Utilisations d'oligosaccharides prebiotiques benefiques pour la flore vaginale
WO2006114061A1 (fr) * 2005-04-27 2006-11-02 Shenzhen Phlora Biotechnology Limited Composition et procédé de régulation et de maintien de la flore bactérienne vaginale et de l'acidité normale dans le vagin

Also Published As

Publication number Publication date
ITMI20091122A1 (it) 2010-12-26

Similar Documents

Publication Publication Date Title
BR112012013148A2 (pt) formulação farmacêutica e uso
EP2441453A4 (en) PHARMACEUTICAL COMPOSITION FOR HUMAN AND ANIMAL MEDICINE OPHTHALMOLOGY
CL2013000481A1 (es) Metodo y para mejorar la eficacia y/o reducir los efectos secundarios de una farmacoterapia administrada de forma suboptima que comprende la administracion de un hexitol sustituido; composicion farmaceutica; combinacion farmaceutica; uso para tratar enfermedades proliferativas.
SMT201500224B (it) Derivati purinici per l'uso nel trattamento di malattie allergiche, infiammatorie e infettive
HUE037082T2 (hu) Új lipidek és készítmények terápiás hatóanyagok szállítására
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
BR112012004970A2 (pt) inibidores de jak2 e seu uso para o tratamento de doenças mieloproliferativas e câncer
CL2011002248A1 (es) Composicion farmaceutica oral de liberacion inmediata que comprende oxicodona y naloxona en una proporcion 2:1 en peso; uso de la composicion farmaceutica para tratar dolor intercurrente en paciente que sufren de dolor.
DOP2011000354A (es) Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas
HK1199401A1 (en) Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
FI2575785T3 (fi) Bendamustiinin oraalisia annostelumuotoja ja niiden terapeuttinen käyttö
BRPI1006040A2 (pt) uso de composições farmacêuticas, tipo de curativo médico, e, tipo de caixa de medicamento
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
GT201200304A (es) Composiciones farmacéuticas que comprenden hidromorfona y naloxona
BR112012013164A2 (pt) composições farmacêuticas para o estímulo de células-tronco
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI1011610A2 (pt) êmbolo para um corpo oco medicinal e corpo oco medicinal
SG10201704712QA (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
BRPI0910570A2 (pt) uso de bioconjugados, e, formulações farmacêuticas
GB201014391D0 (en) Drug composition and its use in therapy
SV2010003773A (es) 7-sulfanilmetil-, 7-sulfinilmetil- y 7-sulfonilmetilindoles sustituidos y el uso de los mismos
ECSP12011951A (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnóstico para una enfermedad parasitaria
IT1398279B1 (it) Formulazioni farmaceutiche per uso intravaginale nella prevenzione e terapia delle vulvo vaginiti e nel ripristino della fisiologia vaginale
IT1402047B1 (it) Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali